Research has already found that semaglutide also known by the brand names Wegovy and Ozempic reduced the risk of death in people who were obese or overweight and had cardiovascular disease.
People who took the drug died at a lower rate from all causes, not just from cardiovascular causes, researchers discovered.
Semaglutide has far-reaching benefits beyond what we initially imagined, said Prof Harlan Krumholz of the Yale school of medicine.
Improving people's health this way actually slows down the ageing process.
[
Collection
]
[
|
...
]